Eton Pharmaceuticals (ETON) will file Form 144 on May 28, signaling potential insider sales of securities.

Eton Pharmaceuticals (ETON) has announced the filing of Form 144 for May 28. Form 144 is typically filed to notify the SEC of potential sales of securities by insiders. This filing may indicate forthcoming transactions involving Eton's stock, which could impact market perceptions and trading activity. Any sales from insiders could affect stock liquidity and investor sentiment moving forward.

Eton Pharmaceuticals (ETON) Form 144 Filing Date Set for May 28

AI Summary

Related News

United Bancorp (UBCP) Director Acquires $22,559 in Common Stock

United Bancorp (UBCP) Director Erin Ball Purchases $9,435 in Stock

Vestis Corp (VST) Stock Reaches 52-Week High at 12.61 USD

Form 144 Texas Instruments Inc Reports Key Share Transactions